Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

INTRODUCTION: This multicenter phase II study determined the efficacy and safety of new daily oral S-1 and weekly irinotecan (CPT-11) combination schedule in patients with previously untreated advanced or recurrent colorectal cancer. PATIENTS AND METHODS: Patients received first-line chemotherapy co...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ogata, Yutaka, Tanaka, Takaho, Akagi, Yoshito, Ishibashi, Nobuya, Tsuji, Yoshiaki, Matono, Keiko, Isobe, Makoto, Sueyoshi, Susumu, Kaibara, Atsushi, Shirouzu, Kazuo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Libertas Academica 2013
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3572922/
https://ncbi.nlm.nih.gov/pubmed/23439317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S10769
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak